Guidelines for the management of gestational diabetes in pregnancy

Clinical Practice

Volumn 9, Issue 2, 2012, Pages 161-170

  Glastras, Sarah ^a   Fulcher, Gregory ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN LISPRO; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

BLOOD GLUCOSE MONITORING; COST EFFECTIVENESS ANALYSIS; DIET THERAPY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HIGH RISK PATIENT; HOME CARE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTRAPARTUM CARE; KINESIOTHERAPY; LIFESTYLE MODIFICATION; MORNING DOSAGE; NUTRITIONAL ASSESSMENT; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PATIENT COUNSELING; PRACTICE GUIDELINE; PREGNANCY DIABETES MELLITUS; PUERPERIUM; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; SIDE EFFECT; WEIGHT GAIN;

EID: 84858049557     PISSN: 20449038     EISSN: 20449046     Source Type: Journal    
DOI: 10.2217/cpr.12.9     Document Type: Review

References (49)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 34(Suppl. 1), S62-S69 (2009).
2. Lawrence JM, Contreras R, Chen W, Sacks DA. Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999-2005. Diabetes Care 31(5), 899-904 (2008).
3. Kim SY, England L, Wilson HG, Bish C, Satten GA, Dietz P. Percentage of gestational diabetes mellitus attributable to overweight and obesity. Am. J. Pub. Health 100(6), 1047-1052 (2010).
4. Metzger BE, Gabbe SG, Persson B et al. International Association of Diabetes and Pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33(3), 676-682 (2010).
5. Karakash SD, Einstein FH. Diabetes in pregnancy: glycemia control guidelines and rationale. Curr. Opin Endocrinol. Diabetes Obes. 18(2), 99-103 (2011). Provides a summary of the available evidence of the usefulness of diagnosing gestational diabetes mellitus (GDM) and summarizes the IADPSG guidelines and recent criticism.
6. Metzger BE, Lowe LP, Dyer AR et al. Hyperglycemia and adverse pregnancy outcomes. N. Engl. J. Med. 358(19), 1991-2002 (2008). This large, multicenter, randomized controlled trial provides evidence of a continuous, linear relationship between maternal hyperglycemia and adverse perinatal outcomes.
7. Crowther CA, Hiller JE, Moss JR et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N. Engl. J. Med. 352(24), 2477-2486 (2005). This randomized controlled trial found that treatment of maternal hyperglycemia in pregnancy was associated with improved perinatal outcomes.
8. Landon MB, Spong CY, Thom E et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N. Engl. J. Med. 361(14), 1339-1348 (2009). This randomized controlled trial provided further evidence that treatment of mild hyperglycemia in pregnancy was associated with reduced risk of macrosomia, shoulder dystocia, cesarean section and pre-eclampsia.
9. Langer O, Yogev Y, Most O, Xenakis EMJ. Gestational diabetes: the consequences of not treating. Am. J. Obstet. Gynecol. 192(4), 989-997 (2005).
10. Alwan N, Tuffnell DJ, West J. Treatments for gestational diabetes. Cochrane Database Syst. Rev. 3, CD003395 (2009). This Cochrane review provides evidence based on eight well-designed randomized controlled trials that treatment of GDM is associated with improved maternal and fetal outcomes.
11. Metzger BE, Buchanan TA, Coustan DR et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 30(Suppl. 2), S251-S260 (2007). These recommendations provide guidance regarding treatment options and targets for GDM. The majority of recommendations are based on consensus opinion of a large group of obstetricians and gynecologists.
12. Ryan EA. Diagnosing gestational diabetes. Diabetologia 54(3), 480-486 (2011).
13. Long H. Diagnosing gestational diabetes: can expert opinions replace scientific evidence? Diabetologia 54(9), 2211-2213 (2011).
14. Cundy T. Proposed new diagnostic criteria for gestational diabetes - a pause for thought? Diabet. Med. 29(2), 176-180 (2011).
15. Omori Y, Jovanovic L. Proposal for the reconsideration of the definition of gestational diabetes. Diabetes Care 28(10), 2592-2593 (2005).
16. Sheffield JS, Butler-Koster EL, Casey BM, Mcintire DD, Leveno KJ. Maternal diabetes mellitus and infant malformations. Obstet. Gynecol. 100(5 Pt 1), 925-930 (2002).
17. Ornoy A. Growth and neurodevelopmental outcome of children born to mothers with pregestational and gestational diabetes. Pediatr. Endocrinol. Rev. 3(2), 104-113 (2005).
18. Dabelea D. The predisposition to obesity and diabetes in offspring of diabetic mothers. Diabetes Care 30(Suppl. 2), S169-S174 (2007).
19. Guideline Development Group. Management of diabetes from preconception to the postnatal period: summary of NICE guidance. BMJ 336(7646), 714-717 (2008).
20. Cosson E, Benchimol M, Carbillon L et al. Universal rather than selective screening for gestational diabetes mellitus may improve fetal outcomes. Diabetes Metab. 32(2), 140-146 (2006).
21. Riskin-Mashiah S, Younes G, Damti A, Auslender R. First-trimester fasting hyperglycemia and adverse pregnancy outcomes. Diabetes Care 32(9), 1639-1643 (2009).
22. Moses RG, Morris GJ, Petocz P, San Gil F, Garg D. The impact of potential new diagnostic criteria on the prevalence of gestational diabetes mellitus in Australia. Med. J. Aust. 194(7), 338-340 (2011).
23. American College of Obstetricians and Gynaecologists. Committee opinion no. 504: screening and diagnosis of gestational diabetes mellitus. Obstet. Gynecol. 2011(118), 751-753 (2011).
24. Cheng YW, Block-Kurbisch I, Caughey AB. Carpenter-Coustan criteria compared with the National Diabetes Data Group thresholds for gestational diabetes mellitus. Obstet. Gynecol. 114(2 Pt 1), 326-332 (2009).
25. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 26(Suppl. 1), S103-S105 (2003).
26. Franz MJ, Bantle JP, Beebe CA et al. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 26(Suppl. 1), S51-S61 (2003).
27. Walkinshaw SA. Dietary regulation for 'gestational diabetes'. Cochrane Database Syst. Rev. 2, CD000070 (2000).
28. Weisz B, Shrim A, Homko CJ, Schiff E, Epstein GS, Sivan E. One hour versus two hours postprandial glucose measurement in gestational diabetes: a prospective study. J. Perinatol. 25(4), 241-244 (2005).
29. Olansky L, Kennedy L. Finger-stick glucose monitoring: issues of accuracy and specificity. Diabetes Care 33(4), 948-949 (2010).
30. Kjos SL, Schaefer-Graf UM. Modified therapy for gestational diabetes using high-risk and low-risk fetal abdominal circumference growth to select strict versus relaxed maternal glycemic targets. Diabetes Care 30(Suppl. 2), S200-S205 (2007).
31. Aydin Y, Berker D, Direktor N et al. Is insulin lispro safe in pregnant women: does it cause any adverse outcomes on infants or mothers? Diabetes Res. Clin. Pract. 80(3), 444-448 (2008).
32. Hod M, Damm P, Kaaja R et al. Fetal and perinatal outcomes in Type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects. Am. J. Obstet. Gynecol. 198(2), 186.e181-e187 (2008).
33. Mathiesen ER, Damm P, Jovanovic L et al. Basal insulin analogues in diabetic pregnancy: a literature review and baseline results of a randomised, controlled trial in Type 1 diabetes. Diabetes Metab. Res. Rev. 27(6), 543-551 (2011).
34. Lapolla A, Di Cianni G, Bruttomesso D et al. Use of insulin detemir in pregnancy: a report on 10 Type 1 diabetic women. Diabet. Med. 26(11), 1181-1182 (2009).
35. Rowan JA, Hague WM, Gao W, Battin MR, Moore MP; MiG trial investigators. Metformin versus insulin for the treatment of gestational diabetes. N. Engl. J. Med. 358(19), 2003-2015 (2008). This study found that metformin therapy for GDM was not associated with increased perinatal complications as compared with insulin.
36. Goh JEL, Sadler L, Rowan J. Metformin for gestational diabetes in routine clinical practice. Diabet. Med. 28(9), 1082-1087 (2011).
37. Rowan JA, Gao W, Hague WM, McIntyre HD. Glycemia and its relationship to outcomes in the Metformin in Gestational Diabetes trial. Diabetes Care 33(1), 9-16 (2010).
38. Vanky E, Zahlsen K, Spigset O, Carlsen SM. Placental passage of metformin in women with polycystic ovary syndrome. Fertil. Steril. 83(5), 1575-1578 (2005).
39. Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N. Engl. J. Med. 343(16), 1134-1138 (2000).
40. Moore LE, Clokey D, Rappaport VJ, Curet LB. Metformin compared with glyburide in gestational diabetes: a randomized controlled trial. Obstet. Gynecol. 115(1), 55-59 (2010). Glyburide was found to be as effective as metformin at achieving glycemic targets in GDM management and patients taking glyburide were found to be less likely to require additional insulin therapy as compared with metformin.
41. Silva JC, Pacheco C, Bizato J, De Souza BV, Ribeiro TE, Bertini AM. Metformin compared with glyburide for the management of gestational diabetes. Int. J. Gynaecol. Obstet. 111(1), 37-40 (2010).
42. Carron Brown S, Kyne-Grzebalski D, Mwangi B, Taylor R. Effect of management policy upon 120 Type 1 diabetic pregnancies: policy decisions in practice. Diabet. Med. 16(7), 573-578 (1999).
43. Kline GA, Edwards A. Antepartum and intra-partum insulin management of Type 1 and Type 2 diabetic women: impact on clinically significant neonatal hypoglycemia. Diabetes Res. Clin. Pract. 77(2), 223-230 (2007).
44. Lepercq J, Abbou H, Agostini C et al. A standardized protocol to achieve normoglycaemia during labour and delivery in women with Type 1 diabetes. Diabetes Metab. 34(1), 33-37 (2008).
45. Jovanovic L. Glucose and insulin requirements during labor and delivery: the case for normoglycemia in pregnancies complicated by diabetes. Endocr. Pract. 10(Suppl. 2), 40-45 (2004).
46. Barrett HL, Morris J, McElduff A. Watchful waiting: a management protocol for maternal glycaemia in the peripartum period. Aust. NZ J. Obstet. Gynaecol. 49(2), 162-167 (2009).
47. Rosenberg VA, Eglinton GS, Rauch ER, Skupski DW. Intrapartum maternal glycemic control in women with insulin requiring diabetes: a randomized clinical trial of rotating fluids versus insulin drip. Am. J. Obstet. Gynecol. 195(4), 1095-1099 (2006).
48. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of Type 2 diabetes: a systematic review. Diabetes Care 25(10), 1862-1868 (2002).
49. Carr DB, Utzschneider KM, Hull RL et al. Gestational diabetes mellitus increases the risk of cardiovascular disease in women with family history of Type 2 diabetes. Diabetes Care 29(9), 2078-2083 (2006).